Bowling Portfolio Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bowling Portfolio Management's BMY Position: Q3 2022 in Review
Bowling Portfolio Management reduced its Bristol-Myers Squibb (BMY) stake by 6.1% in Q3 2022, selling an estimated $102K and leaving 21,660 shares worth $1.54M. The position accounts for 0.42% of the portfolio, ranked #74.
Bowling Portfolio Management first reported a position in BMY in Q2 2018 and has held it in 16 quarters since. The position peaked at $4.76M in Q2 2020. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Bowling Portfolio Management held 21,660 shares of Bristol-Myers Squibb worth $1.54M as of Q3 2022.
- Bowling Portfolio Management sold 1,406 Bristol-Myers Squibb shares in Q3 2022, an estimated $102K.
- Bristol-Myers Squibb made up 0.42% of Bowling Portfolio Management's portfolio in Q3 2022, its #74 holding.
- Bowling Portfolio Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 16 quarters since.
- Bowling Portfolio Management's Bristol-Myers Squibb position peaked at $4.76M in Q2 2020.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.